Koyfin Home > Directory > Health Care > Aduro Biotech > Levered Free Cash Flow (FCF)

Aduro Biotech Levered Free Cash Flow (FCF) Chart (ADRO)

Aduro Biotech annual/quarterly Levered Free Cash Flow (FCF) from 2014 to 2020.
  • Aduro Biotech Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-9m a 35.68% decrease of -3m year over year
  • Aduro Biotech Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-43m a 58.09% decrease of -25m year over year
  • Aduro Biotech Annual Levered Free Cash Flow (FCF) for 2019 was $-35m a -26.56% increase of 9m from 2018
  • Aduro Biotech Annual Levered Free Cash Flow (FCF) for 2018 was $-44m a -29.57% increase of 13m from 2017
  • Aduro Biotech Annual Levered Free Cash Flow (FCF) for 2017 was $-57m a 12.39% decrease of -7m from 2016
Other Cash Flow Metrics:
  • Aduro Biotech Cash Flow from Operations for the quarter ending December 12, 2018 was $-1m a -1,784.81% increase of 20m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO Levered Free Cash Flow (FCF) Data

06/2020$-9m
03/2020$-6m
12/2019$-21m
09/2019$-6m
06/2019$-7m
03/2019$0m
12/2018$-5m
09/2018$-18m
06/2018$-7m
03/2018$-15m

Annual ADRO Levered Free Cash Flow (FCF) Data

2019$-35m
2018$-44m
2017$-57m
2016$-50m
2015$-17m
2014$23m
2013$-10m